PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $84,687 | +123.2% | 3,514 | -2.1% | 0.00% | +100.0% |
| Q4 2022 | $37,936 | +134.9% | 3,589 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $16,151 | +253.6% | 3,589 | +214.3% | 0.00% | – |
| Q2 2022 | $4,568 | -83.9% | 1,142 | -70.5% | 0.00% | -100.0% |
| Q1 2022 | $28,328 | -4.6% | 3,870 | -26.7% | 0.00% | – |
| Q4 2021 | $29,679 | -28.9% | 5,281 | -19.1% | 0.00% | -100.0% |
| Q3 2021 | $41,754 | -64.1% | 6,524 | -52.7% | 0.00% | -50.0% |
| Q2 2021 | $116,174 | -9.7% | 13,781 | +12.4% | 0.00% | 0.0% |
| Q1 2021 | $128,627 | -44.0% | 12,256 | -9.6% | 0.00% | -33.3% |
| Q4 2020 | $229,588 | +32.0% | 13,553 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $173,885 | -9.1% | 13,553 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $191,233 | – | 13,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |